Deepika Jalota - 03 Mar 2025 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role: Chief Development Officer
Signature: /s/ Robert Ticktin, by power of attorney
Issuer symbol: PMVP
Transactions as of: 03 Mar 2025
Net transactions value: $0
Form type: 4
Filing time: 05 Mar 2025, 18:32:27 UTC
Previous filing: 12 Sep 2024
Next filing: 03 Jul 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	PMVP	Common Stock						123,024	03 Mar 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PMVP	Employee Stock Option (right to buy)	Award	$0	+300,000		$0.000000	300,000	03 Mar 2025	Common Stock	300,000	$1.32	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 4,741 shares acquired under the Issuer's Employee Stock Purchase Plan as follows: 2,276 shares acquired on May 20, 2021; 359 shares acquired on November 19, 2021; 993 shares acquired on May 20, 2022 and 1,113 shares acquired on November 21, 2022.
F2	Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2025.